Abvc Biopharma (ABVC) Receivables - Other (2018 - 2025)
Historic Receivables - Other for Abvc Biopharma (ABVC) over the last 9 years, with Q3 2025 value amounting to $546.0.
- Abvc Biopharma's Receivables - Other fell 9995.47% to $546.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $546.0, marking a year-over-year decrease of 9995.47%. This contributed to the annual value of $2667.0 for FY2023, which is 9948.09% down from last year.
- According to the latest figures from Q3 2025, Abvc Biopharma's Receivables - Other is $546.0, which was down 9995.47% from $1.4 million recorded in Q2 2025.
- In the past 5 years, Abvc Biopharma's Receivables - Other registered a high of $1.4 million during Q2 2024, and its lowest value of $546.0 during Q3 2025.
- Over the past 5 years, Abvc Biopharma's median Receivables - Other value was $145399.0 (recorded in 2021), while the average stood at $439709.9.
- Over the last 5 years, Abvc Biopharma's Receivables - Other had its largest YoY gain of 2093873.87% in 2025, and its largest YoY loss of 9995.47% in 2025.
- Abvc Biopharma's Receivables - Other (Quarter) stood at $145399.0 in 2021, then surged by 253.39% to $513819.0 in 2022, then plummeted by 99.48% to $2667.0 in 2023, then soared by 45057.93% to $1.2 million in 2024, then plummeted by 99.95% to $546.0 in 2025.
- Its Receivables - Other was $546.0 in Q3 2025, compared to $1.4 million in Q2 2025 and $537119.0 in Q1 2025.